News Details

( 10/01/2018 13:47)
Lupin Ltd. - Press Release

Lupin Limited has informed the Exchange regarding a press release dated January 10, 2018, titled "Lupin receives FDA approval for generic Tamiflu Capsules".

ATTENTION INVESTORS "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case

SEBI Regn. NSE: INB231280430 I F&O: INF231280430 I BSE: INB011280436 I NSE CD: INE231280430 I MCX-SX: INE261280430

Copyright © 2017 Rikhav Securities Ltd. All rights reserved

Designed , Developed & Content Powered by DION